Spring Bank Pharmaceuticals Inc
01748 Hopkinton, United States
Spring Bank Pharmaceuticals Inc Company Information
Обща информация
Spring Bank Pharmaceuticals is a clinical-stage biopharmaceutical company engaged in the discovery and development of a novel class of therapeutics using our proprietary small molecule nucleic acid hybrid (SMNH) chemistry platform. SMNH compounds are small segments of nucleic acids that the company designs to selectively target and modulate the activity of specific proteins implicated in various disease states. Spring Bank is developing its most advanced SMNH product candidate, inarigivir soproxil (formerly referred to as SB 9200), for the treatment of viral diseases, including hepatitis B virus (HBV), and other SMNH product candidates, including SB 11285, the company's lead immunotherapeutic agent for the treatment of selected cancers through the activation of the STimulator of Interferon Genes, or STING, pathway.
86 South Street Hopkinton
- Работно време
-
Понеделник:08:30 - 17:00Вторник:08:30 - 17:00Сряда:08:30 - 17:00Четвъртък:08:30 - 17:00Петък:08:30 - 17:00
- Паркинг
- Компанията разполага с паркинг.
- Телефонен номер
- +1508-473-5993
- Linki
- Социални акаунти
- Ключови думи
- фармацевтична фирма
Spring Bank Pharmaceuticals Inc Отзиви
Как оценявате тази компания?
Вие ли сте собственик на тази компания? Ако е така, не пропускайте възможността да актуализирате профила на фирмата си, да добавите продукти, оферти и по-висока позиция в търсачките.